Arora Laproscopy Centre Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 23-12-2024
- Paid Up Capital ₹ 2.50 M
as on 23-12-2024
- Company Age 11 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 7.10 Cr
as on 23-12-2024
- Revenue %
(FY 2022)
- Profit 443.19%
(FY 2022)
- Ebitda 141.84%
(FY 2022)
- Net Worth 51.33%
(FY 2022)
- Total Assets 0.39%
(FY 2022)
About Arora Laproscopy Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.50 M.
The company has closed loans amounting to ₹7.10 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Indu Arora and Nareshkumar Arora serve as directors at the Company.
- CIN/LLPIN
U85110GJ2013PTC073787
- Company No.
073787
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Feb 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Surat, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Arora Laproscopy Centre?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Indu Arora  | Director | 28-Feb-2013 | Current |
| Nareshkumar Arora | Director | 28-Feb-2013 | Current |
Financial Performance of Arora Laproscopy Centre.
Arora Laproscopy Centre Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 443.19% increase in profit. The company's net worth Soared by an impressive increase of 51.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arora Laproscopy Centre?
In 2020, Arora Laproscopy Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sahyog Nuclear Imaging And Diagnostics C Entre LlpActive 8 years 10 monthsNareshkumar Arora is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Surat People's Co.Op Bank Ltd. Creation Date: 24 Jun 2013 | ₹2.50 Cr | Satisfied |
The Surat People's Co.Op Bank Ltd. Creation Date: 24 Jun 2013 | ₹4.60 Cr | Satisfied |
How Many Employees Work at Arora Laproscopy Centre?
Unlock and access historical data on people associated with Arora Laproscopy Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arora Laproscopy Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arora Laproscopy Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
